10 Best Biotech Stocks to Invest In According To Billionaire Biotech Hedge Fund
In this article, we will present the 10 best stocks to invest in according to the billionaire biotech hedge fund manager Joe Edelman.
Myokardia Inc. (MYOK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Columbus Circle Investors Principal Global Investors | 0 | $0 | 0% | |
| 2. | Rhenman & Partners Asset Management Henrik Rhenman | 0 | $0 | 0% | |
| 3. | Birchview Capital Matthew Strobeck | 0 | $0 | 0% | |
| 4. | McKinley Capital Management Robert B. Gillam | 0 | $0 | 0% | |
| 5. | CSat Investment Advisory Claes Fornell | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $39.87 | 1,600 | Officer, Director | 88,473 | 2019-01-04 | Filing | |
| $39.84 | 900 | Officer, Director | 86,873 | 2019-01-04 | Filing | |
| $49.00 | 150,000 | Large Shareholder | 4,168,899 | 2018-05-25 | Filing | |
| $35.50 | 1,408 | Director | 1,408 | 2017-08-14 | Filing | |
| $35.50 | 350,000 | Large Shareholder | 4,018,899 | 2017-08-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $96.59 | 21,329 | Director | 2,300 | 2020-06-30 | Filing | |
| $97.25 | 300 | Director | 23,629 | 2020-06-30 | Filing | |
| $98.68 | 371 | Director | 2,300 | 2020-06-29 | Filing | |
| $94.22 | 3,224 | Officer, Director | 19,122 | 2020-07-02 | Filing | |
| $93.55 | 1,776 | Officer, Director | 22,346 | 2020-07-02 | Filing |
Institutional Investors' Holdings
News See All
Were Hedge Funds Right About Crowding Into MyoKardia, Inc. (MYOK)?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Hedge Funds Have Never Been This Bullish On MyoKardia, Inc. (MYOK)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On MyoKardia, Inc. (MYOK) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
MyoKardia, Inc. (MYOK): Hedge Funds Are Snapping Up
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Were Buying MyoKardia, Inc. (MYOK) Before The Coronavirus
We hate to say this but, we told you so.
Were Hedge Funds Right About Flocking Into MyoKardia, Inc. (MYOK) ?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
Here's What Hedge Funds Think About MyoKardia, Inc. (MYOK)
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small...
Hedge Funds Are Buying MyoKardia, Inc. (MYOK)
Is MyoKardia, Inc. (NASDAQ:MYOK) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.